https://www.kcnq2cure.org/?press_release=kcnq2-cure-alliance-receives-250000-commitment-fund-vital-research-rare-form-epileptic-encephalopathy2016-04-06T00:00:00-06:00https://www.kcnq2cure.org/?press_release=kcnq2-cure-alliance-partners-pairnomix-advance-understanding-rare-form-epileptic-encephalopathy2015-12-07T00:00:00-07:00https://www.kcnq2cure.org/?press_release=kcnq2-cure-alliance-jackson-laboratory-collaborate-precision-mouse-models-genetic-epilepsy2015-10-15T00:00:00-06:00https://www.kcnq2cure.org/?press_release=families-lead-quest-precision-medicine-treat-rare-genetic-disorder2015-10-15T00:00:00-06:00https://www.kcnq2cure.org/?press_release=kcnq2-cure-alliance-commences-kcnq2-awareness-week-second-annual-summit2015-03-03T00:00:00-07:00https://www.kcnq2cure.org/?press_release=kcnq2-cure-alliance-foundation-formed-educate-advance-research-patients-living-rare-genetic-disorder-kcnq22014-12-09T00:00:00-07:00https://www.kcnq2cure.org/?press_release=pairnomix-and-kcnq2-cure-alliance-report-findings-from-comprehensive-drug-screening-in-a-cellular-model-of-kcnq2-epileptic-encephalopathy2018-04-12T00:00:00-06:00https://www.kcnq2cure.org/?press_release=ninds-launches-new-epilepsy-center-without-walls2019-04-25T09:51:33-06:00https://www.kcnq2cure.org/?press_release=xenon-expands-ion-channel-neurology-pipeline-with-addition-of-xen496-a-phase-3-ready-potassium-channel-modulator-for-the-treatment-of-epilepsy2019-04-25T09:44:51-06:00https://www.kcnq2cure.org/?press_release=xenon-pharmaceuticals-outlines-2019-key-milestones2019-04-25T09:46:14-06:00https://www.kcnq2cure.org/?press_release=6042019-04-25T09:48:41-06:00https://www.kcnq2cure.org/?press_release=xenon-pharmaceuticals-announces-initiation-of-xen1101-phase-1-clinical-trial2019-04-25T09:49:59-06:00https://www.kcnq2cure.org/?press_release=xenon-pharmaceuticals-reports-2018-financial-results-and-provides-corporate-update2019-04-25T09:51:05-06:00https://www.kcnq2cure.org/?press_release=xenon-pharmaceuticals-reports-third-quarter-2018-financial-results-and-provides-corporate-update2019-04-25T09:53:36-06:00https://www.kcnq2cure.org/?press_release=behind-the-seizure-program-expansion-helps-speed-the-diagnosis-of-genetic-epilepsy-in-younger-children-experiencing-unprovoked-seizures2019-04-25T09:54:44-06:00https://www.kcnq2cure.org/?press_release=knopp-biosciences-presents-positive-preclinical-data-for-lead-neonatal-epilepsy-drug-candidate-at-2019-antiepileptic-drug-and-device-trials-xv-conference2019-05-24T10:57:42-06:00